Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone 12.5 mg Starting Dose in Polymyalgia Rheumatica
NCT01169597Phase 4Completed
- Sponsor
- University of Genoa
- Start
- Jan 2009
- Primary completion
- Jan 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of prednisone in polymyalgia rheumatica (PMR), sponsored by University of Genoa. Primary endpoint: Clinical remission within one month from the treatment initiation at 1 month. Started Jan 2009; status: completed.
02
Drugs
prednisone
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on NCT01169597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01169597.